Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

White Matter Pathways Boosting Dorsolateral TMS Therapy

April 14, 2026
Continue Reading
white-matter-pathways-boosting-dorsolateral-tms-therapy
Posted inBiotechnology

Neuronal Lipid Droplets Govern Energy Balance Differently by Sex

April 14, 2026
Continue Reading
neuronal-lipid-droplets-govern-energy-balance-differently-by-sex
Posted inBiotechnology

Fast, Precise Large-Scale Protein Alignment: FAMSA2

April 14, 2026
Continue Reading
fast,-precise-large-scale-protein-alignment:-famsa2
Posted inBiotechnology

Nanoscale Light Trapping: Pioneering the Future of Optoelectronic Power

April 14, 2026
Continue Reading
nanoscale-light-trapping:-pioneering-the-future-of-optoelectronic-power
Posted inBiotechnology

New Biomarker Identified to Predict Immunotherapy Success in Colon and Rectal Cancer Patients

April 14, 2026
Continue Reading
new-biomarker-identified-to-predict-immunotherapy-success-in-colon-and-rectal-cancer-patients
Posted inBiotechnology

The Protein Society Reveals 2026 Award Recipients

April 14, 2026
Continue Reading
the-protein-society-reveals-2026-award-recipients
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

fda-elevates-boston-scientific-cryoablation-correction-effort-following-four-deaths
Posted inMedical Technology

FDA elevates Boston Scientific cryoablation correction effort following four deaths

December 19, 2024
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation.…
Read More
bms-pays-leqembi-originator-$100m-for-next-gen-preclinical-alzheimer’s-prospects
Posted inBiotechnology

BMS pays Leqembi originator $100M for next-gen preclinical Alzheimer’s prospects

December 19, 2024
Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million…
Read More
roche-reports-failure-of-prothena-partnered-parkinson’s-prospect-in-phase-2b-but-highlights-positives
Posted inBiotechnology

Roche reports failure of Prothena-partnered Parkinson’s prospect in phase 2b but highlights positives

December 19, 2024
Back-to-back clinical failures have dealt further blows to efforts to treat Parkinson’s disease by targeting alpha-synuclein. Days after UCB reported the…
Read More
astellas-pays-sangamo-$20m-upfront-to-improve-neurological-gene-therapy-capabilities
Posted inBiotechnology

Astellas pays Sangamo $20M upfront to improve neurological gene therapy capabilities

December 19, 2024
Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 million upfront to help bypass…
Read More
akamis-bio-raises-$60-million-for-cancer-gene-therapy,-signs-licensing-deal-with-xuanzhu-biopharma
Posted inGenetics

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

December 19, 2024
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…
Read More
mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More
xgen-venture-closes-$190m-fund-with-plans-to-invest-in-early-stage-biotech,-medtech-firms
Posted inBiotechnology

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms

December 18, 2024
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Read More
labcorp-launches-bird-flu-test-amid-first-severe-case-in-the-us
Posted inMedical Technology

Labcorp launches bird flu test amid first severe case in the US

December 18, 2024
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Read More
the-state-of-cell-and-gene-therapy-2025
Posted inGenetics

The State of Cell and Gene Therapy 2025

December 18, 2024
Broadcast Date:  Wednesday, January 29, 2025Time:  8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Read More

Posts pagination

Previous page 1 … 1,669 1,670 1,671 1,672 1,673 … 1,682 Next page
You May Have Missed
stryker-makes-a-buy-as-avalon-to-go-private-in-a-spate-of-medtech-m&a-deals
Posted inMedical Technology

Stryker makes a buy as Avalon to go private in a spate of medtech M&A deals

alamar-biosciences-files-for-ipo-amid-opening-life-sciences-funding-window
Posted inMedical Technology

Alamar Biosciences files for IPO amid opening life sciences funding window

retractable-technologies-trims-staff-to-save-$2.2m-annually-as-tariffs-bite
Posted inMedical Technology

Retractable Technologies trims staff to save $2.2M annually as tariffs bite

harbinger-health-raises-$100m-for-new-suite-of-blood-based-cancer-detection-tests
Posted inMedical Technology

Harbinger Health raises $100M for new suite of blood-based cancer detection tests

Privacy Policy    Terms

Scroll to Top